impassion130 trial data on pd-l1 tumors in tnbc
Published 4 years ago • 93 plays • Length 6:54Download video MP4
Download video MP3
Similar videos
-
6:56
impassion130 trial data on pd-l1 tumors in tnbc
-
1:16
the impassion130 trial in metastatic triple-negative breast cancer
-
4:27
analysis of impassion130: pd-l1 testing in advanced tnbc
-
0:59
impassion130 data demonstrate clinical benefit for immunotherapy in metastatic tnbc
-
7:19
impassion130 trial: os updates in metastatic tnbc
-
6:33
case 3: results of the impassion130 trial in metastatic breast cancer
-
2:33
applying impassion130 data to tnbc management
-
8:42
chemoimmunotherapy in tnbc: the impassion130 trial
-
4:33
i-o in tnbc: impassion130 trial design and results
-
2:30
impassion130: immunotherapy for tnbc
-
4:47
tnbc: updated efficacy results from impassion130
-
5:59
impassion130: atezolizumab and nab-paclitaxel in triple-negative breast cancer
-
4:56
results from the impassion 130 trial treating metastatic breast cancer
-
7:40
study of carboplatin plus nivolumab in metastatic triple-negative breast cancer
-
4:46
performance of pd-l1 ihc assays in impassion130: a post-hoc analysis
-
7:09
personalizing immunotherapy beyond pdl1 expression
-
4:53
results from the impassion130 trial for triple-negative breast cancer
-
1:38
combined analyses of pd-l1 and tils for therapy selection in tnbc
-
3:37
case 3: pd-l1 testing used in triple-negative breast cancer